Rituximab is all the rage – and it should be – but it’s not the only immune modulating drug being tested in ME/CFS.
An immune modulating drug trial that recently opened in the Netherlands, of all places, could open new treatment possibilities as well. Because it will finish up before the Rituximab trial it could provide validation of this disease sooner as well.
It also suggests that attitudes are shifting in some surprising places.
Find out more about this encouraging drug trial in
▪ Immune Modulating Chronic Fatigue Syndrome Trial Suggests Changes Occurring
Why is the Netherlands a strange place – “of all places” – for this to occur? Is there a very imperial attitude at play here that the USA is the “leader of the world”? What’s going on?
Given it’s size, wealth and power the USA is totally underperforming in its contribution to CFS research and advances!
There is no reason to throw around such accusations.
I live in a smaller and much poorer country than Netherlands and I would use the same words as Mr. Johnson.
The prevalent attitude in Netherlands among doctors and researchers has been for years that ME/CFS is a purely psychological disease, so to see a study done on ME/CFS that looks at immune system rather than the psyche, to quote Mr. Johnson, means “attitudes are shifting”